CN107970353A - A kind of medicine for treating pharyngitis - Google Patents
A kind of medicine for treating pharyngitis Download PDFInfo
- Publication number
- CN107970353A CN107970353A CN201711430957.XA CN201711430957A CN107970353A CN 107970353 A CN107970353 A CN 107970353A CN 201711430957 A CN201711430957 A CN 201711430957A CN 107970353 A CN107970353 A CN 107970353A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- pharyngitis
- leaf
- herb
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of medicine for treating pharyngitis, which is made of the traditional Chinese medicinal components that following weight ratio forms：Leaf of negundo chastetree, Paris polyphylla, iron holly bark , Jia Betel, dandelion, roadside chrysanthemum, Common Achyranthes Herb, wears floricome, the five fingers mandarin orange, ligustrum sinense leaf, stone precipice tea, Sculellaria barbata, Glabrous Sarcandra Herb, selaginella doederlleini, radix ranunculi ternati.The medicine is having the effect of swelling and pain relieving, anti-inflammatory in terms for the treatment of pharyngitis, and drug side-effect is low, is a kind of active drug that can be widely popularized for treating pharyngitis securely and reliably, clinical meaning is notable.
Description
Technical field
The present invention relates to a kind of medicine for treating pharyngitis, belongs to the field of Chinese medicines.
Background technology
It is pharyngeal mucosa to fall pharyngitis, and the inflammation of submucous tissue, is often a part for the infection of the upper respiratory tract.According to the course of disease
Length and pathological change property difference, be divided into acpuei pharyngitis, two major class of chronic pharyngitis, it is also possible to produce complication, such as：
The lower respiratory tracts such as larynx, tracheae can be invaded, cause acute laryngitis, tracheitis, bronchitis and pneumonia；If pathogenic bacteria and toxin are invaded
Enter blood circulation, then can cause systemic complications, such as acute nephritis, septicopyemia, rheumatism, it is very big to body harm.It is existing
In most of pharyngitis patients to have Western medicine and treat the methods of with antibiotic, although these medicines have the effect of certain, but still not
Can be satisfactory.
The content of the invention
The purpose of the present invention is further excavate and utilize effective prescription in pools of traditional Chinese medicine, there is provided prescription uniqueness,
The medicine of low, safe and reliable, the evident in efficacy treatment pharyngitis of cost.
In order to achieve the above object, the present invention uses following technical scheme：
A kind of medicine for treating pharyngitis, it is characterised in that be made of following raw material components and weight proportion：50 parts of leaf of negundo chastetree, Paris polyphylla
25 parts, 10 parts of 10 parts of , Jia Betel of iron holly bark, 40 parts of dandelion, 35 parts of roadside chrysanthemum, 15 parts of Common Achyranthes Herb, wears 5 parts of floricome, the five fingers mandarin orange 6
Part, 25 parts of ligustrum sinense leaf, 10 parts of stone precipice tea, 25 parts of Sculellaria barbata, 25 parts of Glabrous Sarcandra Herb, 10 parts of selaginella doederlleini, 15 parts of radix ranunculi ternati.
Pharmaceutical composition preparation process of the present invention is simple to operation, active compound is easy to get, of low cost, it then follows the prescription of the traditional Chinese medical science is used
Medicine principle, adverse reaction and side effect significantly reduce, and safety coefficient is high, verifies by clinic application, its is curative for effect, mild in medicine property
With do not occur toxic side effect and serious adverse reaction, can preferably treat pharyngitis.Drug moiety title of the present invention is recorded in extensively
Western Zhuang autonomous region strengthens medicine quality standard.
Embodiment
The present invention is further described below by way of specific embodiment, but the present invention is not limited only to implement in detail below
Example.Within the scope of the invention or do not departing from present disclosure, in spirit and scope, the change that is carried out to the present invention,
Combination is replaced, and will be apparent to the person skilled in the art, and be included within the scope of the present invention.
Embodiment 1
50 parts of leaf of negundo chastetree, 25 parts of Paris polyphylla, 10 parts of 10 parts of , Jia Betel of iron holly bark, 40 parts of dandelion, 35 parts of roadside chrysanthemum, Common Achyranthes Herb 15
Part, wear 5 parts of floricome, 6 parts of the five fingers mandarin orange, 25 parts of ligustrum sinense leaf, 10 parts of stone precipice tea, 25 parts of Sculellaria barbata, 25 parts of Glabrous Sarcandra Herb, selaginella doederlleini 10
Part, 15 parts of radix ranunculi ternati.
Usage：Said medicine is pulverized and mixed uniformly in proportion, each taking 5 grams, twice daily.
Treat the experimental study of pharyngitis
1 data and method
1 .1 general information
Certain traditional Chinese medical science Out-patient Department pharyngitis patient 100 is chosen, male 54, women 46, at 15~72 years old age, average age is
（54 .17±19 .68）Year；Light-duty 29 of the state of an illness, 57 medium-sized, 14 heavy, average course of disease（50 .48±3 .55）My god.
All patients are randomly divided into control group and each 50 of observation group, in observation group patient, male 28, and women 22, average age
For（54 .15±19 .66）In year, light-duty 15 of the state of an illness is 29 medium-sized, 6 heavy, and average course of disease is（5 .68±3 .45）
My god.In control group patient, male 26, women 24, average age is（54 .11±19 .65）Year, light-duty 14 of the state of an illness,
28 medium-sized, 8 heavy, average course of disease is（50 .33±3 .65）My god.The data such as two groups of patient ages, gender, courses of disease compare
It is not statistically significant（P>0 .05）, it is comparable.
1 .2 methods
Control group uses merely western medicine：According to pathogenic factor（Virus, bacterial species）Difference gives different western medicines,
Common cephalo, penicillin, erythromycin are Ji An Benzyl penicillin etc..Observation group uses on the basis of control group chemotherapy plus uses the present invention
Medicine, 5g/ times, 2 times/d, take orally.Two groups to treat 21d as 1 course for the treatment of.Curative effect evaluation is carried out after the course for the treatment of,
Reenact further therapeutic scheme.
1 .3 curative effect determinate standards
Remission simultaneously has a greater degree of improvement to be effective, and sings and symptoms disappears for recovery from illness, and symptom is without substantially changeing as nothing
Effect.
1 .4 statistical procedures
Statistical analysis carries out the data obtained using SPSS17 .0 softwares, measurement data is examined using t, and enumeration data uses χ 2
Examine, P<0 .05 has statistical significance for difference.
2 results
After treatment, effective 37 of observation group, effective 12, invalid 1, total effective rate 98.0%；Control group effective 24
Example, effective 20, invalid 6, total effective rate 88.0%, is shown in Table 1.
1 two groups of patient's curative effects of table compare ［ n（%）
Two groups of total effective rate comparing differences have statistical significance（0 .05 of P ＜）, observation group's clinical efficacy is substantially compared with control group
It is good.
Experimental example 2：Model case
Huge XX, man, 46 years old, acpuei pharyngitis patient, cardinal symptom be onset urgency, from the beginning of when pharyngeal drying, it is scorching hot；Can be occurred together heat,
Headache, loss of appetite；Invade and throat, can accompanying sound neigh and cough.Pharmaceutical composition prepared by the present invention is taken, every time 1 .5g, often
It 2 times, discharge of fully recovering after even served 3 weeks.
XX is opened, female, 31 years old, patients with chronic pharyngitis, cardinal symptom was pharyngeal discomfort, does, itches, secretion cusalgia more, easily
It is dry to dislike, there are foreign body sensation, not out.Aggravated when after slightly more, edible irritable food of speaking, tired or Changes in weather.Take
Pharmaceutical composition prepared by the present invention, 1 .5g, fully recovers leave hospital 2 times a day, after even served 4 weeks every time.
Claims (1)
1. a kind of medicine for treating pharyngitis, it is characterised in that be made of following raw material components and weight proportion：50 parts of leaf of negundo chastetree, weight
25 parts of building, 10 parts of 10 parts of , Jia Betel of iron holly bark, 40 parts of dandelion, 35 parts of roadside chrysanthemum, 15 parts of Common Achyranthes Herb, wears 5 parts of floricome, the five fingers mandarin orange
6 parts, 25 parts of ligustrum sinense leaf, 10 parts of stone precipice tea, 25 parts of Sculellaria barbata, 25 parts of Glabrous Sarcandra Herb, 10 parts of selaginella doederlleini, 15 parts of radix ranunculi ternati.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711430957.XA CN107970353A (en) | 2017-12-26 | 2017-12-26 | A kind of medicine for treating pharyngitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711430957.XA CN107970353A (en) | 2017-12-26 | 2017-12-26 | A kind of medicine for treating pharyngitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107970353A true CN107970353A (en) | 2018-05-01 |
Family
ID=62007614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711430957.XA Pending CN107970353A (en) | 2017-12-26 | 2017-12-26 | A kind of medicine for treating pharyngitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107970353A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101396522A (en) * | 2007-09-29 | 2009-04-01 | 李廷树 | Medicine for treating pharyngitis |
| CN105560997A (en) * | 2016-01-25 | 2016-05-11 | 济南星懿医药技术有限公司 | Medicine composition for treating pharyngitis |
| CN105998632A (en) * | 2016-07-22 | 2016-10-12 | 赵月 | Pharmaceutical composition for treating pharyngitis |
-
2017
- 2017-12-26 CN CN201711430957.XA patent/CN107970353A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101396522A (en) * | 2007-09-29 | 2009-04-01 | 李廷树 | Medicine for treating pharyngitis |
| CN105560997A (en) * | 2016-01-25 | 2016-05-11 | 济南星懿医药技术有限公司 | Medicine composition for treating pharyngitis |
| CN105998632A (en) * | 2016-07-22 | 2016-10-12 | 赵月 | Pharmaceutical composition for treating pharyngitis |
| CN106138695A (en) * | 2016-07-22 | 2016-11-23 | 赵月 | A kind of pharmaceutical composition for treating acute pharyngitis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103520395B (en) | Traditional Chinese medicine composition for treating lung cancer | |
| CN104127661A (en) | Traditional Chinese medicine oral liquid for treating non-small cell lung cancer | |
| CN104013846A (en) | Traditional Chinese medicine composition for treating dental ulcer and application thereof | |
| CN100389802C (en) | Medicine for treating and preventing chronic obstractive pneumonia | |
| CN102335373B (en) | Chinese medicinal composition for treating upper respiratory tract infection, and preparation method thereof | |
| CN103816281B (en) | A kind of Chinese medicine composition of prevention and treatment anemopyretic cold | |
| WO2006007758A1 (en) | Traditional chinese medicine composition for treating acute and chronic nasosinusitis and preparation thereof | |
| CN102697984B (en) | Chinese medicinal external application preparation for treating acute mastitis | |
| CN107970353A (en) | A kind of medicine for treating pharyngitis | |
| CN103230418B (en) | Mycelium extract for helicobacter pylori-resistant biological medicine and preparation technology thereof | |
| CN105343503B (en) | A kind of pharmaceutical composition that treating sphagitis and its application | |
| CN104225405A (en) | Chinese medicinal buccal tablet for treating respiratory tract infection and preparation method | |
| CN104815151A (en) | Traditional Chinese medicine for treating warm-dryness lung injury type cough | |
| CN108355124A (en) | A kind of Chinese medicine composition that treating Air way mucus hypersecretion and its application | |
| CN103566141B (en) | A kind of preparation method for the treatment of the medicament of chronic pharyngitis | |
| CN103638189B (en) | The Chinese medicine preparation for the treatment of acute pharyngitis | |
| CN102319290B (en) | Medicament for preventing cancer cells from proliferating to lungs after radiation treatment of nasopharyngeal darcinoma | |
| CN108653552B (en) | Traditional Chinese medicine for clearing lung and relieving cough | |
| CN106938041A (en) | It is a kind of to treat Chinese medicine preparation of gastric ulcer and preparation method thereof and its medicinal usage | |
| CN114869948A (en) | Traditional Chinese medicine composition for treating chronic tracheitis and chronic bronchitis and application thereof | |
| CN104906378A (en) | Traditional Chinese medicine composition for treating cough with lung heat | |
| Chen et al. | Theoretical basis and clinical application of tumors due to spleen deficiency and dampness | |
| Hua et al. | Combination of Qingfei Huayu Decoction and Targeted Nursing Care Improves the Clinical Outcomes in Pediatric Patients with Mycoplasma Pneumoniae Pneumonia | |
| CN104922525A (en) | Traditional Chinese medicine composition for treating pulmonary abscess | |
| WO2016078152A1 (en) | Chill-dispelling traditional chinese medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180501 |